| Outline of Final Research Achievements |
Through collaborative research with Dr. Richard O'Connell, three significant outcomes were achieved. Firstly, it was suggested that the target of compounds identified by the applicant in their basic project, which possess effector secretion inhibition effects, may not be the EV secretion mechanism. Secondly, new technology was established in the Brassicaceae anthracnose fungus, a plant pathogenic filamentous fungus, leading to publication in an international journal as a co-authored paper. Thirdly, using the aforementioned technology, it became possible to elucidate the functions of key factors contributing to the pathogenicity of the anthracnose fungus. These results are scheduled for submission as an international co-authored paper by 2024, with some of the findings planned for patent application. Thus, this support has borne fruit in the form of multiple original papers, patent applications, and ongoing collaborative research efforts.
|
